The short answer is: not exactly. Testosterone does not directly cause hair loss, but it does serve as the raw material for a hormone that does. That hormone is dihydrotestosterone (DHT), and its relationship to your hair follicles is the real story behind androgenetic alopecia. Understanding the distinction between testosterone and DHT clarifies why some men with high testosterone keep a full head of hair while others with average levels go significantly bald.
What Causes the Testosterone-Hair Loss Connection
Testosterone is converted into DHT by an enzyme called 5-alpha reductase, primarily in the skin, liver, and prostate. ( 1 ) Once formed, DHT binds to androgen receptors in hair follicles located at the temples and crown of the scalp. In genetically susceptible men, this binding triggers a process of follicular miniaturization: the growth phase of each hair cycle shortens, and the follicle gradually produces finer, weaker hairs until it eventually becomes dormant. ( 2 )
Crucially, the process depends on genetic sensitivity rather than the amount of DHT present. Men with highly sensitive androgen receptors in their follicles will experience significant hair loss even at normal DHT levels. Men whose follicles lack this sensitivity may retain a full head of hair regardless of their hormonal profile. ( 3 )
This is why the bald-equals-high-testosterone myth persists but does not hold up to scrutiny. If you want to understand more about how testosterone functions in the body, see our overview of what low testosterone actually means.
The Science: DHT, Receptors, and Genetic Predisposition
The androgen receptor (AR) gene, located on the X chromosome, plays a central role in hair loss susceptibility. ( 4 ) Variants of this gene influence how strongly follicular androgen receptors respond to DHT. Men who inherit high-sensitivity variants experience more aggressive follicle miniaturization at any given DHT concentration.
However, the AR gene is not the whole story. Genome-wide association studies have identified more than 200 genetic loci associated with androgenetic alopecia, meaning the trait is highly polygenic. ( 5 ) Genes inherited from both parents contribute to baldness risk, which is why a man can go bald even if his father had a full head of hair into old age.
DHT levels themselves vary between men based on 5-alpha reductase activity, testosterone production, and other androgen-related hormones including DHEA-S and androstenedione. Research published in the Journal of Investigative Dermatology has shown that scalp tissue from balding areas contains significantly higher concentrations of DHT and greater 5-alpha reductase activity than hair-bearing areas of the same scalp. ( 6 ) This regional sensitivity is what makes the crown and temples vulnerable while the sides and back remain resistant.
Treatment Options That Target DHT
Because DHT is the key driver of androgenetic alopecia, treatments that reduce DHT or block its receptor activity are the most effective approaches for genetically susceptible men.
5-Alpha Reductase Inhibitors
Finasteride and dutasteride work by blocking 5-alpha reductase, which reduces the conversion of testosterone to DHT. In a multicenter clinical trial published in the New England Journal of Medicine, men taking finasteride demonstrated significant improvement in hair count and slowing of hair loss progression compared to those taking placebo. ( 7 ) These medications require a prescription and ongoing use to maintain results.
Minoxidil
Minoxidil does not address DHT directly. Instead, it works by prolonging the anagen (growth) phase of the hair cycle and improving blood flow to follicles. ( 8 ) It is often used alongside finasteride for a complementary approach: one targets the hormonal cause, and the other supports follicle function independent of hormonal mechanisms.
Hormonal Evaluation
In some cases, hair loss can be associated with broader hormonal imbalances. Reviewing your normal testosterone levels by age and discussing them with a physician can rule out secondary causes of hair thinning, including elevated prolactin or thyroid dysfunction.
Common Myths About Testosterone and Hair Loss
Myth: High testosterone causes baldness. DHT sensitivity determines hair loss risk, not total testosterone. Many men with above-average testosterone levels retain their hair throughout life. ( 9 )
Myth: Lowering testosterone will stop hair loss. Artificially reducing testosterone does not reliably prevent hair loss in men who are genetically predisposed. The relevant variable is DHT at the follicle level, which is why targeted enzyme inhibitors are more effective than broad hormonal suppression.
Myth: Hair loss skips a generation. Because androgenetic alopecia is polygenic, it does not follow simple dominant or recessive inheritance. A man can inherit hair loss risk from numerous ancestors across multiple generations.
Myth: Testosterone therapy always accelerates hair loss. This is more nuanced. Some men on testosterone therapy notice accelerated thinning; others do not. The outcome depends on their genetic sensitivity to DHT and whether DHT-blocking treatments are used concurrently. Read more about this in our article on testosterone replacement therapy.
When to See a Doctor
If you are noticing hair thinning at the temples or crown before age 30, it is worth seeing a physician sooner rather than later. Earlier intervention with proven treatments yields better outcomes. A physician can confirm whether the pattern matches androgenetic alopecia or whether another condition such as alopecia areata, scalp inflammation, or a nutritional deficiency is contributing. ( 10 )
Blood work to assess total and free testosterone, DHT, thyroid hormones, and other markers can provide useful context, especially if you are also experiencing fatigue, changes in body composition, or reduced libido alongside hair loss.
Get Clarity on Your Hair Loss
If you have been blaming your testosterone for your hairline, the picture is more complex. Genetics, DHT sensitivity, and enzyme activity all play larger roles than raw testosterone numbers. The good news is that the mechanisms driving hair loss are well understood, and effective tools exist to slow or reverse it. Start with a proper evaluation from a men’s health physician who can assess both your hormonal profile and your hair loss pattern together.
Emergency Notice: If you or someone else is experiencing a medical emergency, call 911 immediately. The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
References
- Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186(4170):1213–1215. https://doi.org/10.1126/science.186.4170.1213
- Sinclair R. Male pattern androgenetic alopecia. BMJ. 1998;317(7162):865–869. https://doi.org/10.1136/bmj.317.7162.865
- Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Reviews in Molecular Medicine. 2002;4(22):1–11. https://doi.org/10.1017/S1462399402005112
- Hillmer AM, Hanneken S, Ritzmann S, et al. Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. American Journal of Human Genetics. 2005;77(1):140–148. https://doi.org/10.1086/431425
- Heilmann-Heimbach S, Herold C, Hochfeld LM, et al. Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness. Nature Communications. 2017;8:14694. https://doi.org/10.1038/ncomms14694
- Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. Journal of Investigative Dermatology. 1997;109(3):296–300. https://doi.org/10.1111/1523-1747.ep12335779
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. New England Journal of Medicine. 1998;338(15):1033–1037. https://doi.org/10.1056/NEJM199804093381512
- Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. British Journal of Dermatology. 2004;150(2):186–194. https://doi.org/10.1111/j.1365-2133.2004.05785.x
- Trüeb RM. Molecular mechanisms of androgenetic alopecia. Experimental Gerontology. 2002;37(8–9):981–990. https://doi.org/10.1016/S0531-5565(02)00093-1
- Tosti A, Piraccini BM. Diagnosis and treatment of hair disorders: an evidence-based atlas. Dermatologic Clinics. 2013;31(1):1–8. https://doi.org/10.1016/j.det.2012.09.001